Iron-catalyzed production of reactive oxygen species is a cause of liver injury after ischemia/ reperfusion (I/R). The aim of the present study was to address the regulation of transferrin receptor (TfR), which mediates cellular iron uptake, during I/R. The molecular mechanisms controlling TfR gene expression in vivo during I/R of rat liver were investigated by molecular biology procedures. We also analyzed transferrin-bound iron uptake into surviving liver slices. Increased amounts of TfR protein and messenger RNA (mRNA) were found 2 to 6 hours after reestablishment of blood supply. RNA bandshift analysis showed that iron regulatory protein (IRP) activity was decreased in the first hours of reperfusion, thus indicating that IRP-mediated mRNA stabilization was not involved in early TfR upregulation. On the contrary, increased transcription of the TfR gene in isolated nuclei was observed during reperfusion; during the ischemic phase this was preceded by enhanced binding of hypoxia inducible factor (HIF-1) to a DNA sequence derived from the TfR promoter. TfR2 mRNA levels were also enhanced after reperfusion. The increased expression of TfR at the cell surface resulted in increased uptake of transferrin-bound-iron into surviving liver slices; however, iron was not incorporated into ferritin. T he cell has to constantly face the difficult task of balancing the need for iron with the toxicity of this metal. The maintenance of intracellular iron homeostasis depends on the balanced expression of ferritin, which stores iron in a soluble nontoxic form, and transferrin receptor (TfR), which mediates iron uptake. 1,2 The tight reciprocal regulation of these 2 proteins ensures that the levels of the metal are adequate for cellular iron needs but remain below the threshold required to become a source of toxic reactive oxygen species (ROS). Ferritin and TfR expression is controlled at multiple levels, 1,2 but intracellular iron homeostasis is mainly regulated by means of post-transcriptional mechanisms. 3,4 In fact, in addition to individual transcriptional controls, 1,2 the genes for ferritin and TfR share a common regulatory pathway mediated by iron regulatory proteins (IRP-1 and IRP-2). When iron inside the cell is scarce, iron regulatory elements (IRE) in ferritin and TfR messenger RNAs (mRNAs) are bound by iron regulatory proteins (IRP-1 and 2), which block their translation and degradation, respectively (see reviews [3][4][5][6][7][8][9] ). This determines a simultaneous increase in iron uptake and decrease in iron sequestration that results in the formation of a pool of free iron available for metabolic use. Conversely, when iron is abundant, IRP-1 assembles a 4Fe-4S cluster, loses its RNA-binding activity and acquires enzymatic activity as a cytoplasmic aconitase, whereas IRP-2 is degraded via the ubiquitin-proteasome pathway. Under the latter condi-